RxDoctor Payments Data

Janis Nicholson, APRN

Psychiatric/Mental Health · Newington, CTNPI 1700952413

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 24.8% of the total. Among psychiatric/mental health clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,338in general payments, 2019–2025

Across 53 payments — averaging $100.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Axsome Therapeutics, Inc.$1K
  • Otsuka America Pharmaceutical, Inc.$846
  • Alkermes, Inc.$571
  • Teva Pharmaceuticals USA, Inc.$455
  • Jazz Pharmaceuticals Inc.$244
  • plus $744 from 7 others

What the payments were for

  • Food & beverage$5,338100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,338 in reported general payments places this provider in the 90th percentile of 679 psychiatric/mental health providers in Connecticut.

See all psychiatric/mental health providers in Connecticut

Medicare billing

Part B allowed, 2024
$45,485
Medicare patients
29
Services billed
483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Bupropion XlBupropion Hcl68$2,001
Triazolam12$1,048
Escitalopram Oxalate42$788
Sertraline Hcl53$692
Clonazepam45$676
Duloxetine Hcl44$670
Lorazepam105$633
Trazodone Hcl21$460
Lamotrigine19$452
Fluoxetine Hcl29$413
Alprazolam64$408
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine11$388
Quetiapine Fumarate ErQuetiapine Fumarate13$366
Venlafaxine Hcl13$321
Bupropion Hcl SrBupropion Hcl19$236

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Newington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →